WO2000073420A3 - Creation of human tumorigenic cells and uses therefor - Google Patents
Creation of human tumorigenic cells and uses therefor Download PDFInfo
- Publication number
- WO2000073420A3 WO2000073420A3 PCT/US2000/015008 US0015008W WO0073420A3 WO 2000073420 A3 WO2000073420 A3 WO 2000073420A3 US 0015008 W US0015008 W US 0015008W WO 0073420 A3 WO0073420 A3 WO 0073420A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- creation
- tumorigenic cells
- cells
- uses therefor
- human somatic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
Disclosed are tumorigenic human somatic cells produced by introducing exogenous DNA into normal (parental) human somatic cells, in which the DNA is expressed, resulting in production of tumorigenic human somatic cells; progeny of the parental cells are also tumorigenic. Methods of producing tumorigenic human somatic cells and uses for the cells are also disclosed.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13707499P | 1999-06-02 | 1999-06-02 | |
US60/137,074 | 1999-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000073420A2 WO2000073420A2 (en) | 2000-12-07 |
WO2000073420A3 true WO2000073420A3 (en) | 2001-07-12 |
Family
ID=22475723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/015008 WO2000073420A2 (en) | 1999-06-02 | 2000-06-01 | Creation of human tumorigenic cells and uses therefor |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2000073420A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7585622B1 (en) | 1996-10-01 | 2009-09-08 | Geron Corporation | Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
GB2321642B8 (en) | 1996-10-01 | 2006-08-22 | Geron Corp | Human telomerase reverse transcriptase promoter |
US7622549B2 (en) | 1997-04-18 | 2009-11-24 | Geron Corporation | Human telomerase reverse transcriptase polypeptides |
US7413864B2 (en) | 1997-04-18 | 2008-08-19 | Geron Corporation | Treating cancer using a telomerase vaccine |
US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
US7358262B2 (en) * | 2003-01-29 | 2008-04-15 | Whitehead Institute For Biomedical Research | Identification of genotype-selective anti-tumor agents |
US8252591B2 (en) | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
US20110244502A1 (en) | 2007-08-10 | 2011-10-06 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
-
2000
- 2000-06-01 WO PCT/US2000/015008 patent/WO2000073420A2/en active Application Filing
Non-Patent Citations (5)
Title |
---|
BODNAR ANDREA G ET AL: "Extension of life-span by introduction of telomerase into normal human cells.", SCIENCE (WASHINGTON D C), vol. 279, no. 5349, 16 January 1998 (1998-01-16), pages 349 - 352, XP002157587, ISSN: 0036-8075 * |
COUNTER C M ET AL: "Dissociation among in vitro telomerase activity, telomere maintenance and cellular immoratization", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,NATIONAL ACADEMY OF SCIENCE. WASHINGTON,US, vol. 95, December 1998 (1998-12-01), pages 14723 - 14728, XP002130650, ISSN: 0027-8424 * |
HAHN W C ET AL: "Creation of human tumour cells with defined genetic elements", NATURE,MACMILLAN JOURNALS LTD. LONDON,GB, vol. 400, 27 July 1999 (1999-07-27), pages 464 - 468, XP002130651, ISSN: 0028-0836 * |
RHEINWALD J G ET AL: "Properties of immortal cell lines arising from human epidermal keratinocytes stably transfected to express hTERT (human telomerase catalytic subunit).", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL, vol. 40, March 1999 (1999-03-01), 90th Annual Meeting of the American Association for Cancer Research;Philadelphia, Pennsylvania, USA; April 10-14, 1999, March, 1999, pages 726, XP002157585, ISSN: 0197-016X * |
ZHU JIYUE ET AL: "Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 96, no. 7, 30 March 1999 (1999-03-30), March 30, 1999, pages 3723 - 3728, XP002157586, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000073420A2 (en) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6837696A (en) | Chimeric animal and method for constructing the same | |
PL322611A1 (en) | Methods of obtaining l-amini acid by fermentation, dna as well as micro-organism | |
AU2002210991A1 (en) | Novel glucose dehydrogenase and process for producing the dehydrogenase | |
WO2003014336A1 (en) | Process for preparing hematopoietic stem cells | |
EP1538202A3 (en) | Production of human alpha-galactosidase A | |
MXPA02003733A (en) | Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells. | |
ATE414782T1 (en) | METHOD FOR PRODUCING POLYPEPTIDES IN MUTATED ASPERGILLUS CELLS | |
WO2001036589A3 (en) | Human ex vivo immune system | |
WO2003024406A3 (en) | Nestin-expressing hair follicle stem cells | |
AU3108099A (en) | Membrane process for producing carbon dioxide | |
AU2002336930A1 (en) | Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture | |
WO2001055101A3 (en) | A new process for the preparation of latanoprost | |
WO2000073420A3 (en) | Creation of human tumorigenic cells and uses therefor | |
HK1068275A1 (en) | Pine cone extracts and uses thereof | |
WO2000029551A3 (en) | Cells, culture methods, and their use in autologous transplantation therapy | |
WO2003006612A3 (en) | Production of transduced hematopoietic progenitor cells | |
WO2004013288A3 (en) | Methods and kits for synthesis of sirna expression cassettes | |
WO2005017100A8 (en) | Ribonucleases and methods of making them recombinantly | |
AU2002303277A1 (en) | Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells | |
WO2005012498A3 (en) | Production of porphyrins | |
AU2002243235A1 (en) | Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production | |
AU1609900A (en) | Method for the massive culture of cells producing recombinant human erythropoietin | |
AU4771600A (en) | Cells, culture methods and their uses | |
WO2000004918A3 (en) | Agents for the immunotherapy of tumoral diseases | |
EP1371722A4 (en) | Ribonucleic acid-enriched brewer's yeast cells and process for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |